TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
SRZN

Surrozen Inc

Healthcare · Biotechnology

33.70$ +108.4% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow SRZN
Line item 2019 2020 2021 2022 2023 2024 2025
– – – – – – –
– -15.2% +6.7% -5.4% -2.3% -24.5% -62.8%
– -19.6% +264.7% +95.0% -3.2% -5.9% -6.8%
– +12.2% +145.1% – – – –
– – -525.0% – – – –
– -44.1% +45.2% -42.6% -45.3% -93.5% +392.3%
– +864.5% +415.5% – +35.0% -100.1% +392.3%
– – – – – – –
– -92.3% +0.0% +260,600.0% -99.8% – +110.6%
– +73.2% +149.0% -102.1% – +5,760.9% +425.8%
– -80.1% -132.2% – – -112.7% –
– – – – – – –

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?